Meridian Bioscience reported $212.47M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Accelerate Diagnostics AXDX:US 48.06M 13.05M
Atrion ATRI:US 137.57M 1M
Becton, Dickinson and BDX:US $ 9547M 605M
Bio Rad Laboratories BIO:US $ 3249.7M 53.72M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Cerus CERS:US $ 164.67M 8.14M
Meridian Bioscience VIVO:US $ 212.47M 5.09M
Myriad Genetics MYGN:US $ 367.1M 60.3M
Orasure Technologies OSUR:US $ 267.31M 1.06M
Quidel QDEL:US $ 1559.1M 554.55M
Sientra SIEN:US 117.97M 16.97M
Staar Surgical STAA:US $ 296.46M 22.55M
Thermo Fisher Scientific TMO:US $ 18100M 676M
Trinity Biotech TRIB:US $ 58.27M 14.42M
Utah Medical Products UTMD:US $ 78.95M 3.11M